Holen Sie sich die Stockscreener-App
100.09
1.01%
-1.02
Handel nachbörslich:
98.50
-1.59
-1.59%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Carl Icahn raises shared share stake in Centuri Holdings, dissolves in Dana, Illumina - MarketScreener
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know - Yahoo Finance
Now that NGS is more affordable, how can we make it easier? - Illumina
Illumina’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Illumina Settles $9.8M False Claims Case Over Vulnerable Genomic Systems - WebProNews
[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know - TradingView
Illumina Sees Future Rebound in China Sales - San Diego Business Journal
Daiwa Securities Downgrades Illumina to Neutral From Outperform, Adjusts Price Target to $94 From $124 - MarketScreener
US Personalized Medicine Market Trends and Company Analysis - GlobeNewswire
US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche - Yahoo Finance
How Illumina Inc. stock performs during market volatilityMaximum Yield Stock Screener - classian.co.kr
Standard BioTools Announces SomaLogic Sale to Illumina - TipRanks
Latest Cybersecurity False Claims Act Settlement with Diagnostics Provider Focuses on Sensitive Health Systems - Inside Privacy
Illumina price leans on SMA supportForecast today11-08-2025 - Economies.com
DNA Microarray Market to Grow at 9% CAGR, Driven by Personalized - openPR.com
Single Cell Genome Sequencing Market is evolving rapidly Through 2025 To 2032 | Illumina, Inc., Fludigim Corporation - openPR.com
Is Illumina Inc. a strong growth stockEarnings Surprise Driven Picks - thegnnews.com
What makes Illumina Inc. stock price move sharplyMulti-Sector Diversified Watchlist - thegnnews.com
What are analysts’ price targets for Illumina Inc.Weekly Oversold Bounce Candidates - thegnnews.com
DOJ Settlement With Medical Technology Company Signals Expanding Cybersecurity FCA Risk for Life Sciences Companies - JD Supra
Illumina (NASDAQ:ILMN) Strong Profits May Be Masking Some Underlying Issues - simplywall.st
Illumina Settles With DOJ, Veterans to End Whistleblower Lawsuit Over Genomic Sequencing Systems with Cybersecurity Vulnerabilities - AInvest
DOJ Secures First of Its Kind Cybersecurity False Claims Act Settlement - JD Supra
Bioinformatics Market Booms with Rapid Growth Expected by 2032 | Active Motif, Inc., Illumina - openPR.com
Illumina Reaches $9.8M Deal in Cybersecurity False Claims Probe - Homeland Security Today
Illumina Stock Slides 0.69 as Mixed Analyst Reactions Highlight 490th-Ranked Volume Amid Profitability Surge and Growth Doubts - AInvest
Illumina pays $9.8 million to settle DOJ claims over cybersecurity failures in government contracts - teiss
“False” Sense of Security: DOJ Announces False Claims Act Settlements Related to Failure to Comply with Cybersecurity Requirements - JD Supra
Does Illumina (ILMN) have an Attractive Risk-Reward Opportunity for Long-Term Investors? - MSN
Illumina Inc. to Pay $9.8M to Resolve False Claims Act Allegations Arising from Cybersecurity Vulnerabilities in Genomic Sequencing Systems - Sierra Sun Times
Illumina (ILMN) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Illumina, Inc. Just Recorded A 76% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st
DOJ reaches USD 9.8M settlement with Illumina - Medical Buyer
Genomic Systems Maker Settles Cybersecurity Lawsuit - Manufacturing Business Technology
DOJ reaches $9.8M settlement with Illumina over cyber whistleblower claims - MedTech Dive
Unexpected Trends Reshaping the U.S. Genomics Market by 2032 - openPR.com
Insider Buying Surges at BEEX Holdings: Chubb and Illumina Lead the Way - AInvest
How the U.S. Precision Medicine Market Will Evolve by 2032 - openPR.com
Illumina’s SomaLogic acquisition may face GRAIL-like regulatory hurdles - ION Analytics
Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued? - au.finance.yahoo.com
Multi-Omics Market to Surpass US$33.25 Billion by 2033, Driven - openPR.com
Illumina Second Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Illumina: The Stock Is Still Undervalued (NASDAQ:ILMN) - Seeking Alpha
Illumina Settles Allegations of Cyber Vulnerabilities in Genomic Sequencing for $9.8M - Claims Journal
What catalysts could drive Illumina Inc. stock higher in 2025Capitalize on market trends with confidence - Jammu Links News
What is Illumina Inc. company’s growth strategyGame-changing returns - jammulinksnews.com
What are Illumina Inc. company’s key revenue driversSuperior stock growth - Jammu Links News
Should I hold or sell Illumina Inc. stock in 2025Extraordinary market timing - Jammu Links News
Illumina, Inc.'s (NASDAQ:ILMN) Stock Is Going Strong: Have Financials A Role To Play? - simplywall.st
How does Illumina Inc. compare to its industry peersBuild a balanced portfolio for long-term success - Jammu Links News
Published on: 2025-08-03 17:43:00 - Jammu Links News
What is the dividend policy of Illumina Inc. stockBreakthrough profits - Jammu Links News
Illumina Inc. Stock Analysis and ForecastDiscover stock picks with superior returns - Jammu Links News
How strong is Illumina Inc. company’s balance sheetInvest confidently with professional guidance - Jammu Links News
1.12%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):